Baronsmead Venture Trust PLC (BVT), a venture capital trust investing in UK smaller companies, has allotted 901,301 new ordinary shares of 10 pence each on 19 November 2026 as part of a joint fundraising offer with Baronsmead Second Venture Trust plc. The shares were issued at an average price of 47.58 pence per share, with the offer seeking to raise up to £20 million in aggregate alongside an over-allotment facility of up to a further £15 million. Admission to the London Stock Exchange's main market is expected on or around 23 November 2026, a development investors in the VCT sector will be monitoring closely.

Key Points

  • Baronsmead Venture Trust PLC (BVT), managed by Gresham House
  • 901,301 new ordinary shares allotted on 19 November 2026 at an average issue price of 47.58 pence per share
  • Issue prices ranged between 46.37 pence and 48.78 pence, based on net asset value per share as at 31 October 2026
  • Investors should watch for Admission confirmation on or around 23 November 2026 and any further allotments under the offer

Joint Prospectus With Baronsmead Second Venture Trust Targets Up to £35 Million in Aggregate

The fundraising underpinning this allotment was launched via a prospectus published on 14 October 2026, jointly by Baronsmead Venture Trust plc and Baronsmead Second Venture Trust plc. The offer seeks to raise up to £20 million in aggregate across both trusts, with the discretion to deploy over-allotment facilities of up to a further £15 million in aggregate. The structure allows each trust to benefit from combined investor interest while maintaining separate share classes and voting rights, which is a common approach among linked VCT pairs seeking to maximise fundraising efficiency within FCA-regulated offer frameworks.

New Shares Priced Between 46.37p and 48.78p Based on 31 October 2026 Net Asset Value

The 901,301 new ordinary shares were issued across a price range of 46.37 pence to 48.78 pence per share, with the precise price for each application determined by the allotment formula set out in the prospectus. Variables including offer costs, any initial commission waived, initial adviser charges, and any early subscription incentive applicable to individual applications all influenced the final issue price. The pricing was anchored to the net asset value per ordinary share as at 31 October 2026, which the company had published on 9 November 2026, providing a transparent, NAV-linked pricing mechanism for subscribers.

Total Voting Rights Reach 443,767,325 Following BVT Share Issuance

Following the allotment, the total number of ordinary shares in issue stands at 516,420,292, which includes 72,652,967 shares currently held in treasury. The total voting rights in the company amount to 443,767,325, the figure shareholders must use as the denominator when calculating whether they are required to notify interests under the Disclosure Guidance and Transparency Rules. The new ordinary shares rank pari passu with existing shares and will be eligible for settlement through CREST from Admission. Definitive documents of title are expected to be dispatched within 10 business days of allotment.

LSE Main Market Admission for BVT New Shares Expected on or Around 23 November 2026

An application will shortly be made for the new ordinary shares to be admitted to trading on the London Stock Exchange's main market for listed securities. The company states that Admission is expected to occur and that dealings will commence on or around 23 November 2026. The shares will be issued in registered form and may be held in uncertificated form via CREST. Investors participating in the offer should note that the new shares are conditional on Admission, meaning the allotment does not become unconditional until that milestone is formally completed.